SCHEMBL8026239

SCHEMBL8026239

[O-][n+]1ccc(Cl)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14283394 0.70
SCHEMBL838061 0.70
SCHEMBL8800727 0.67
SCHEMBL7039373 0.65
SCHEMBL133666 0.64
SCHEMBL4906133 0.61 KMT2A (0.36)
SCHEMBL7617771 0.60 MAPT (0.42)
SCHEMBL3477590 0.56 CYP1A2 (0.48)
SCHEMBL588013 0.56
SCHEMBL4901963 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0974586-A1 2-amino-4-alkylamino-pyrimidine 3-oxydes and compositions containing same L'OREAL (FR) 2000-01-26 EP disclosed
WO-1989007595-A1 SPIROAZA DERIVATIVES OF HETEROCYCLIC N-OXIDES AND THEIR USE IN HAIR GROWTH PROMOTION BAZZANO GAIL S (US) 1989-08-24 WO disclosed
US-4232154-A Carbocyclic analogs of cytosine nucleosides exhibiting antiviral and antineoplasticactivity UNITED STATES OF AMERICA (US) 1980-11-04 US disclosed
US-4177348-A VIRICIDES, ANTINEOPLASTIC, ANTILEUKEMIA, ANTICANCER UNITED STATES GOVERNMENT (US) 1979-12-04 US disclosed
US-3998827-A HYPOTENSIVE AGENTS THE UPJOHN COMPANY (US) 1976-12-21 US disclosed